Myriad Genetics, Inc. MYGN focuses on the expansion of companion diagnostics, market expansion through new clinical guidelines and providing new offerings in its Oncology business. The company ...

Myriad Genetics Inc. Annual stock financials by MarketWatch. View the latest MYGN financial statements, income statements and financial ratios.

Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns ...

Read about Myriad Genetics Inc (MYGN:XNAS) stock and today's latest news and financial updates.

Learn about the executive team and board of directors at Myriad Genetics Inc (MYGN:XNAS) and review their bios and compensation over the latest fiscal years.

Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors.

Get the latest insights on Myriad Genetics, Inc. Common Stock (MYGN) historical NOCP to help you in your trading and investing decisions.

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...